434P CodeBreaK 101 subprotocol H: Phase Ib study evaluating combination of sotorasib (Soto), a KRASG12C inhibitor, and panitumumab (PMab), an EGFR inhibitor, in advanced KRAS p.G12C-mutated colorectal cancer (CRC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Fakih, M; Falchook, GS; Hong, DS; Yaeger, RD; Chan, E; Mather, O; Cardona, P; Dai, T; Strickler, J

Published Date

  • September 2021

Published In

Volume / Issue

  • 32 /

Start / End Page

  • S551 - S551

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2021.08.955